Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
作者信息
Honore Patrick M, De Bels David, Barreto Gutierrez Leonel, Redant Sebastien, Gallerani Andrea, Boer Willem
机构信息
ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein, 4, Brussels, Belgium.
Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine & Pain Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium.
出版信息
Crit Care. 2019 Sep 4;23(1):297. doi: 10.1186/s13054-019-2584-5.
Abstract
摘要
相似文献
1
Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
Crit Care. 2019 Sep 4;23(1):297. doi: 10.1186/s13054-019-2584-5.
2
PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
Contrib Nephrol. 2010;167:83-90. doi: 10.1159/000315922. Epub 2010 Jun 1.
3
[Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
G Ital Nefrol. 2006 May-Jun;23 Suppl 36:S94-102.
4
Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber.
Prog Clin Biol Res. 1988;264:337-41.
5
Polymyxin B for endotoxin removal in sepsis.
Lancet Infect Dis. 2011 Jun;11(6):426-7. doi: 10.1016/S1473-3099(11)70131-1.
6
[Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
Nihon Geka Gakkai Zasshi. 1993 Aug;94(8):775-80.
7
Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
Am J Surg. 2004 Aug;188(2):150-6. doi: 10.1016/j.amjsurg.2003.12.067.
8
Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature.
Contrib Nephrol. 2010;167:77-82. doi: 10.1159/000315921. Epub 2010 Jun 1.
9
Endotoxin removal: how far from the evidence? The EUPHAS 2 Project.
Contrib Nephrol. 2010;167:119-125. doi: 10.1159/000315926. Epub 2010 Jun 1.
10
Endotoxin adsorption: Direct hemoperfusion with the polymyxin B-immobilized fiber column (PMX).
Transfus Apher Sci. 2017 Oct;56(5):682-688. doi: 10.1016/j.transci.2017.08.015. Epub 2017 Aug 31.
引用本文的文献
1
Endotoxin hemoadsorption in refractory septic shock with multiorgan dysfunction and extreme endotoxin activity.
Crit Care. 2025 May 20;29(1):206. doi: 10.1186/s13054-025-05371-1.
本文引用的文献
1
Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial.
Intensive Care Med. 2018 Dec;44(12):2205-2212. doi: 10.1007/s00134-018-5463-7. Epub 2018 Nov 23.
2
The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
Crit Care. 2018 Oct 26;22(1):279. doi: 10.1186/s13054-018-2077-y.
3
Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.
JAMA. 2018 Oct 9;320(14):1455-1463. doi: 10.1001/jama.2018.14618.
4
The digestive tract as the origin of systemic inflammation.
Crit Care. 2016 Oct 18;20(1):279. doi: 10.1186/s13054-016-1458-3.
5
Quantitative lipopolysaccharide analysis using HPLC/MS/MS and its combination with the limulus amebocyte lysate assay.
J Lipid Res. 2015 Jul;56(7):1363-9. doi: 10.1194/jlr.D059725. Epub 2015 May 28.
Zotero 插件